Achieving path-dependent equity for global COVID-19 vaccine allocation

Anthony D So; Joshua Woo

doi:10.1016/j.medj.2021.03.004

Achieving path-dependent equity for global COVID-19 vaccine allocation

Med. 2021 Apr 9;2(4):373-377. doi: 10.1016/j.medj.2021.03.004. Epub 2021 Mar 19.

Authors

Anthony D So^{1

2}, Joshua Woo^{1

2}

Affiliations

¹ Innovation + Design Enabling Access (IDEA) Initiative, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
² Transformative Technologies and Institutions Theme, Johns Hopkins Alliance for a Healthier World, Baltimore, MD 21205, USA.

Abstract

Committing to global access for COVID-19 vaccines is key to avoiding a resurgence of the pandemic. However, agreements between countries and vaccine manufacturers have undermined a globally coordinated approach, and the ongoing vaccine rollout highlights long-standing inequities in health. Yet, the surest path out of this pandemic is one toward greater equity.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Vaccines / therapeutic use
COVID-19* / epidemiology
Humans
Pandemics / prevention & control
Vaccines*

Substances

COVID-19 Vaccines
Vaccines